Document is current
Any future updates will be listed below
-
Authors
Komiya, Kosaku https://orcid.org/0000-0002-8679-1661
Hirano, Yoko https://orcid.org/0000-0003-2151-2083
Kamei, Kazumasa https://orcid.org/0000-0001-7220-5142
Yoshida, Asuka https://orcid.org/0000-0002-9606-2470
Morii, Junko
Kobayashi, Ryohei
Sato, Reiko https://orcid.org/0000-0003-2785-7103
-
Funding
Funding for this research was provided by:
Pfizer Japan
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 30 May 2025
First Online: 6 July 2025
Declarations
:
: Kosaku Komiya has received consultation fees from Pfizer Japan Inc. and received honoraria for delivering promotional lectures from Pfizer Japan Inc., GlaxoSmithKline K.K., Shionogi & Co., Ltd., Meiji Seika Pharma Co., Ltd., and MSD K.K. Yoko Hirano, Kazumasa Kamei, and Asuka Yoshida are employees of Pfizer Japan Inc. Reiko Sato is an employee of Pfizer Inc. Junko Morii and Ryohei Kobayashi are employees of IQVIA Solutions Japan G.K. IQVIA was paid by Pfizer Japan Inc. for conducting the study and medical writing support.
: This study was based on previously published data and does not contain any new studies that required human participants or animals.
